InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30

$15.61+3.41 (+27.94%)

Close on Nov 11, 2026Market cap $85.75MP/E –Yield –

InMed Pharmaceuticals statistics

48 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $85.75M; $282.97M
Enterprise Value: $84.65M; $154.96M

Share statisticsIndustry

Shares Outstanding: 5M; 58M
Shares Change (YoY): 150.7%; 10.9%
Shares Change (QoQ): 2.89%; 0.51%
Float: 4M; 49M
Shares Held by Insiders: 25.5%; 11.6%
Shares Held by Institutions: 49.1%; 56.4%

Stock price statisticsIndustry

52-Week High: $23.30; –
52-Week Low: $5.70; –
20-Day Moving Average: $14.90; –
50-Day Moving Average: $14.02; –
200-Day Moving Average: $12.20; –
Average True Range (14): $2.03; –
Price Change (1 Week): -10.8%; -0.50%
Price Change (1 Month): 17.4%; -0.33%
Price Change (3 Months): 9.15%; -17.2%
Price Change (6 Months): 146.2%; -20.1%
Price Change (YTD): 47.3%; -20.1%
Price Change (1 Year): -3.65%; -19.3%
Price Change (3 Years): -79.9%; -23.4%
Price Change (5 Years): -99.8%; -76.4%
Average Volume (10 Days): 28,290; –
Average Volume (20 Days): 17,708; –
Average Volume (90 Days): 69,191; –
Relative Volume: 0.88; 0.73
Relative Strength Index (14): 53.0; 47.6
Volatility (1 Year): 160.5%; 80.2%
Beta (5 Years): 2.18; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -253.4%; -51.3%
Return on Assets (ROA): -179.5%; -40.3%

EfficiencyIndustry

Profits Per Employee: -$2.19M; -$680.86K
Employee Count: 6; 75
WACC: 15.8%; 10.1%

Income statement (TTM)Industry

Pretax Income: -$11.66M; -$13.50M
Net Income: -$13.16M; -$21.57M
EBITDA: -$11.50M; -$16.36M
EPS (Diluted): -$2.90; -$0.77

Balance sheetIndustry

Cash & Short-Term Investments: $1.10M; $65.30M
Net Cash (Debt): $1.10M; $16.31M
Net Cash Per Share: $0.20; $0.70
Equity (Book Value): -$1.20M; $53.12M
Book Value Per Share: -$0.22; $1.49
Tangible Book Value: -$1.20M; $26.11M

Cash flow (TTM)Industry

Operating Cash Flow: -$7.86M; -$12.07M

Dividends and yieldsIndustry

Earnings Yield: -15.4%; -19.8%

Scores and fair valueIndustry

Altman Z-Score: -121.58; 0.28
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	MTRI	S&P 500	Difference	MTRI per year	S&P 500 per year
1 month	+14.8%	-2.4%	+17.2 pts
3 months	+6.9%	-1.2%	+8.1 pts
Year to date	+47.3%	+12.3%	+35.0 pts
1 year	-10.3%	+12.4%	−22.7 pts
3 years	-79.9%	+78.8%	−158.7 pts	-41.5%	+21.4%
5 years	-99.8%	+75.2%	−174.9 pts	-70.3%	+11.9%

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?